Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Global Organs-on-chips Market (2020-2025) by Type, Application, End-user Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Organs-on-chips Market is estimated to be USD 23.86 Mn in 2020 and is expected to reach USD 98.9 Mn by 2025, growing at a CAGR of 32.9%.Market DynamicsThe growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and new products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure. Recent Developments
Company ProfilesSome of the companies covered in this report are 4DCell, Ascendance Biotechnology, Inc., AxoSim Technologies LLC, BeonChip, BiomimX SRL, Cherry Biotech, CN Bio Innovations, CN Biosystems, Elveflow, Emulate, Inc., HemoShear, TissUse GmbH, uFluidix Inc., etc. Competitive QuadrantThe report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Why buy this report?
Key Topics Covered: 1 Report Description2 Research Methodology3 Executive Summary4 Market Overview4.1 Introduction 4.2 Market Dynamics4.2.1 Drivers4.2.1.1 Growing Focus on Developing Alternatives for Animal Testing Models4.2.1.2 Significant Increase in Research Funding and Venture Capital Investments for the Development of Organs-on-Chips4.2.1.3 Technological Advancements and New Products Launches4.2.1.4 Growing Number of Partnerships and Collaborations between Pharmaceutical Companies and Organs-on-Chips Manufacturers4.2.1.5 Growing Need for Early Detection of Drug Toxicity to Minimize Financial Losses Due to Late Stage Drug Failure4.2.1.6 Growing Initiatives to Increase Awareness about Organs-on-Chips Technologies4.2.2 Restraints4.2.2.1 Issues Related to the Incorporation of Organs-on-Chips Technologies Into Existing Workflows4.2.3 Opportunities4.2.3.1 Increasing Focus on Drug Discovery Activities4.2.3.2 Application of Organs-on-Chips in Oncology Research4.2.3.3 Development of Multiple-Organs-on-A-Chip Models4.2.4 Challenges4.2.4.1 Complexity of Organs-on-Chips Models4.2.4.2 Dearth of Skilled Professionals4.3 Trends5 Market Analysis5.1 Porter's Five Forces Analysis5.2 Impact of COVID-195.3 Ansoff Matrix Analysis6 Global Organs-on-chips Market, By Type6.1 Introduction6.2 Liver6.3 Heart6.4 Lung6.5 Other Organ Types7 Global Organs-on-chips Market, By Application7.1 Introduction7.2 Drug Discovery7.3 Toxicology Research7.4 Other Applications8 Global Organs-on-chips Market, By End User8.1 Introduction8.2 Pharmaceutical and Biotechnology Companies8.3 Academic and Research Institutes8.4 Other End Users9 Global Organs-on-chips Market, By Geography10 Competitive Landscape10.1 Competitive Quadrant10.2 Market Share Analysis10.3 Competitive Scenario10.3.1 Mergers & Acquisitions10.3.2 Agreement, Collaborations, & Partnerships10.3.3 New Product Launches & Enhancements10.3.4 Investments & Funding11 Company Profiles11.1 4DCell11.2 Ascendance Biotechnology, Inc.11.3 AxoSim Technologies LLC11.4 BeonChip11.5 BiomimX SRL11.6 Cherry Biotech11.7 CN Bio Innovations11.8 CN Biosystems11.9 Elveflow11.10 Emulate, Inc.11.11 HemoShear11.12 Hurel Corporation11.13 InSphero AG,11.14 Kirkstall11.15 Mesobiotech11.16 Micronit11.17 Mimetas B.V.11.18 Nortis Inc.11.19 Organovo Holdings, Inc.11.20 SynVivo11.21 Tara Biosystems Inc.11.22 TissUse GmbH11.23 uFluidix Inc.For more information about this report visit
